UAE to begin Phase III trials of Russian Covid-19 vaccine

SourceGulf Business
CountryUAE Top Picks

The UAE has commenced Phase III clinical trials of a Russian adenovirus-based Covid-19 vaccine, officials confirmed on Monday, October 12. Volunteers for the UAE trial will be medically supervised for 90 days after being administered the vaccine. The Russian Direct Investment Fund (RDIF) – Russia’s sovereign wealth fund, is partnering with Aurugulf Health Investment for the UAE trials. “The UAE has demonstrated one of the most advanced approaches in the world to combat the coronavirus pandemic. We are pleased to commence the trials and we look forward to announcing in due course the registration process for volunteers,” said RDIF CEO Kirill Dmitriev. “As part of the Phase III trials of the vaccine, we are planning to expand in several other countries over the coming months, and we are delighted that Abu Dhabi will more...